Rashmi Deshmukh

9PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Optical technologyVision scienceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 20, 2026
Long-term outcome of collagen cross-linking (CXL) for progressive keratoconus with coexistent Fuchs endothelial corneal dystrophy.

|Jul 20, 2026
Pseudokeratoconus in geleophysic dysplasia: a diagnostic pitfall.

|Jun 16, 2026
Progressive inferior keratoconus in a patient misdiagnosed as pellucid marginal corneal degeneration.

|Nov 26, 2025
Oxidative-stress related increase in keratoconus tear MDA and GPX3 while NRF2-antioxidant functions decrease in stromal cells.

Madhuri A Koduri, Mackenzie Charter, Rohini Sonar

|Sep 18, 2025
Outcomes of Collagen Crosslinking in Patients with Keratoconus and Co-Existent Limbal Stem Cell Deficiency.

Rashmi Deshmukh, Eeshita Agarwal, Swapna Shanbhag

|Mar 10, 2021
Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases.

Rashmi Deshmukh, Darren Shu Jeng Ting, Ahmad Elsahn

Pageof 2

Frequent Collaborators

1 joint publications

Imran Mohammed

1 joint publications

Harminder Singh Dua

1 joint publications

Rasik B Vajpayee

1 joint publications

Madhuri A Koduri